Waters (WAT) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is WAT's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

MILFORD, Mass., Nov. 17, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.…

I rate International Seaways a Buy: my $123.56 dividend-discount valuation implies 17.4% upside from $105.23. INSW's spot exposure captures elevated tanker rates amid persistent regional shipping risks; reserve replenish…

WAT gains FDA clearance for two blood cancer diagnostic tests, advancing standardized testing and expanding its clinical diagnostics portfolio.…

BD OneFlow™ LST and BD OneFlow™ B-CLPD T1 Tests now FDA 510(k)-cleared in U.S. for identifying B-cell non-Hodgkin lymphoma (NHL) Delivers 96.3% sensitivity and 98.2% specificity1 in identifying chronic lymphocytic leukem…

WAT expands its proteomics footprint with the MOBILion acquisition, boosting mass spectrometry capabilities, AI-driven research and clinical testing prospects.…

The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvi…

Waters NYSE: WAT reported third-quarter 2026 revenue of $1.767 billion and adjusted earnings per share of $4.10, as the company cited double-digit organic growth, improving performance in acquired businesses and cost act…

WAT beats Q3 2026 earnings and revenue estimates, fueled by acquisitions and strong organic growth and raises its full-year revenue and earnings outlook.…

Waters Corporation (WAT) Q3 2026 Earnings Call Transcript…

The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago…

Waters (WAT) came out with quarterly earnings of $4.1 per share, beating the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $3.4 per share a year ago.…

Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highlights Total reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growt…

Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds, complementing Waters' industry leading mass spectrometry platform, transform…

WAT's Q3 results are likely to benefit from strong revenue growth prospects, rising demand and acquisition gains.…

Advances Waters' strategy to bring trusted AI, ML, and automation capabilities to the 500,000 Empower™ Software users who run the world's regulated chromatography labs and support the release of over 80% of medicines glo…

WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.…

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, …

WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.…

Expands access to most comprehensive FDA-approved HPV test and at-home self-collection option across Quest's national clinician, health plan, and consumer channels starting in 2027 First and only FDA-approved HPV test th…

Investors looking beyond artificial intelligence (AI) should closely watch two healthcare names – Thermo Fisher Scientific (TMO) and Waters (WAT) – according to Josh Brown. In his latest report, the Ritholtz' chief execu…

Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables Leverages Waters' uniq…

Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.…

Shares of Waters Corporation (NYSE: WAT - Get Free Report) hit a new 52-week high during trading on Tuesday. The stock traded as high as $454.54 and last traded at $444.9030, with a volume of 52745 shares changing hands.…

MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m.…

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced a partnership with Waters Corporation to ensure patients have access to the most comprehensive at-home HPV cervical cancer screening…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 8. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

